Personal Injury News & Developments

Articles Tagged with Humira warnings

Abbott Laboratories issued some serious warnings for one of its popular drugs Humira (also known as adalimumab).  Humira acts by blocking TNF (tumor necrosis factor – involved in inflammatory and immune responses) which can cause inflammation and lead to immune-system disease.

Humira is used to treat conditions such as Crohn’s Disease, Rheumatoid Arthritis, Plaque Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis, and Juvenile Idiopathic Arthritis.  Other TNF blockers include Remicade (infliximab), Enbrel (etanercept), Cimzia (certolizumab pegol), and Simponi (golimumab).

Warnings on Humira packaging